BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 4994822)

  • 1. Heterologous antilymphocyte serum. Influence of immunogenicity on immunosuppressive properties.
    Raju S; Grogan JB
    Transplantation; 1969 Nov; 8(5):695-703. PubMed ID: 4994822
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies with anti-lymphocytic antibody and antibody-fragments.
    James K
    Prog Immunobiol Stand; 1970; 4():256-64. PubMed ID: 4394821
    [No Abstract]   [Full Text] [Related]  

  • 3. Induction of immunologic tolerance to antilymphocyte globulin in man.
    Gewurz H; Moberg AW; Simmons RL; Pollara B; Gunnarsson A; Soll R; Najarian JS
    Surg Forum; 1969; 20():259-61. PubMed ID: 4986402
    [No Abstract]   [Full Text] [Related]  

  • 4. The immunological significance of taxonomic origin of protein antigen in chickens.
    Iványi J; Valentová V
    Folia Biol (Praha); 1966; 12(1):36-48. PubMed ID: 4958074
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the decline in immunosuppressive potency of rabbit anti-mouse thymocyte sera raised by repeated immunization of the same rabbit.
    Ponsford FM; Symes MO
    Folia Biol (Praha); 1971; 17(4):227-35. PubMed ID: 5002373
    [No Abstract]   [Full Text] [Related]  

  • 6. Suppression of the development of primary antibacterial immunity by heterologous anti-lymphocyte serum.
    Réthy L; Padányi M
    Acta Vet Acad Sci Hung; 1969; 19(4):405-15. PubMed ID: 4909689
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanisms of immunosuppression by heterologous anti-lymphocyte serum (ALS) and plasma (ALP).
    Jeejeebhoy HF; Rabbat AG; Vela-Martinez JM
    Int Z Klin Pharmakol Ther Toxikol; 1970 May; 3(2):132-7. PubMed ID: 4913082
    [No Abstract]   [Full Text] [Related]  

  • 8. More immunosuppressives needed.
    Nature; 1969 Mar; 221(5183):805-6. PubMed ID: 5765049
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro assay for antilymphocyte serum.
    Bach JF
    Fed Proc; 1970; 29(1):120-2. PubMed ID: 4904618
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bases of antilymphocytic globulin and its therapeutic possibilities].
    Brendel W
    Arzneimittelforschung; 1970 Feb; 20(2):191-7. PubMed ID: 4191782
    [No Abstract]   [Full Text] [Related]  

  • 11. Pathological effects and mode of action of antilymphocyte serum treatment.
    Turk JL
    Fed Proc; 1970; 29(1):136-41. PubMed ID: 4244017
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative effectiveness of anti-lymphocyte serum (A.L.S.) and imuran with respect to suppression of hemagglutinin formation and skin homograft rejection.
    Israel DE; de Vries MJ
    Rev Eur Etud Clin Biol; 1970 Jan; 15(1):102-4. PubMed ID: 4392611
    [No Abstract]   [Full Text] [Related]  

  • 13. Heterologous antilymphocyte serum (ALS) hastens the appearance of methylcholanthrene-induced tumours in mice.
    Rabbat AG; Jeejeebhoy HF
    Transplantation; 1970 Feb; 9(2):164-6. PubMed ID: 4905925
    [No Abstract]   [Full Text] [Related]  

  • 14. Mode of recovery from the effects of heterologous anti-lymphocyte serum. I. Recovery of the immune response.
    Jeejeebhoy HF; Singla O
    Immunology; 1972 May; 22(5):789-99. PubMed ID: 4553773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of antilymphocyte serum (ALS) on the secondary immune response in mice.
    Marshall VR; Knight PR
    Aust J Exp Biol Med Sci; 1969 Apr; 47(2):275-80. PubMed ID: 4978602
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of heterologous antilymphocyte serum on the immunoreactivity of mice].
    Andreson RK
    Biull Eksp Biol Med; 1970 Mar; 69(3):84-7. PubMed ID: 4928082
    [No Abstract]   [Full Text] [Related]  

  • 17. The intravenous administration of equine antilymphocytic globulin in renal transplant recipients and the detection of circulating antibodies to equine globulin.
    James K; Pullar DM; Morton JB; Dalton RG; Nolan B; Woodruff MF
    Clin Exp Immunol; 1971 Apr; 8(4):529-42. PubMed ID: 4995934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship of lymphopenia production and lymphocyte agglutinating and cytotoxic antibody titers to the immunosuppressive potency of heterologous antilymphocyte plasma.
    Jeejeebhoy HF
    Transplantation; 1967 Jul; 5(4):Suppl:1121-6. PubMed ID: 4963509
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antilymphocytic serum].
    Policlinico Prat; 1968 Jul; 75(27):883-6. PubMed ID: 4174248
    [No Abstract]   [Full Text] [Related]  

  • 20. The antigenic and immunosuppressive properties of normal and antilymphocytic equine IgG subfractions.
    Allardyce RA; Anderson NF; Vaerman JP; James K
    Clin Exp Immunol; 1973 Feb; 13(2):263-78. PubMed ID: 4120853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.